Showing results (201-210 of 264) with videos related to

Sort By:
Pageof 27
Human Pathology|August 6, 2014
BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphomaSamantha L Kendrick, Lucas Redd, Andrea Muranyi, et al.
Cell|July 4, 2020
TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory FateLeandro Venturutti, Matt Teater, Andrew Zhai, et al.
Cancer Discovery|March 9, 2013
TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemiaTakaomi Sanda, Jeffrey W Tyner, Alejandro Gutierrez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2017
A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell LymphomaMyron S Czuczman, Marek Trněný, Andrew Davies, et al.
Blood|June 29, 2012
A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphomaAnamarija M Perry, Teresa M Cardesa-Salzmann, Paul N Meyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracyWilliam W L Choi, Dennis D Weisenburger, Timothy C Greiner, et al.
Cancer Discovery|May 4, 2023
Targeting N-linked Glycosylation for the Therapy of Aggressive LymphomasSebastian Scheich, Jiji Chen, Jiamin Liu, et al.
Blood|January 9, 2014
Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissueDavid W Scott, George W Wright, P Mickey Williams, et al.
Cancer Cell|May 30, 2017
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS LymphomaMichail S Lionakis, Kieron Dunleavy, Mark Roschewski, et al.
Haematologica|May 6, 2021
MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphomaJoan Enric Ramis-Zaldivar, Blanca Gonzalez-Farre, Alina Nicolae, et al.
Pageof 27